- Clone
- A21140B (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Cytotoxic T-lymphocyte protein 4, Otal4, CTLA-4, Cytotoxic T-lymphocyte-associated
- Isotype
- Rat IgG1, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
![A.
A21140B_ULEAF_CD152_Block_041924 A.
A21140B_ULEAF_CD152_Block_041924](https://d1spbj2x7qk4bg.cloudfront.net/Admin/Public/GetImage.ashx?Image=/Files/Images/media_assets/products/product_images/A21140B_ULEAF_CD152_Block_041924.png&Width=240&Height=300&altFmImage_path=&Compression=90&Crop=5)
-
Biotinylated recombinant mouse (CTLA-4)-Fc chimera (Cat. No. 779102) (black circles) binds to immobilized recombinant mouse CD86-FC chimera (Cat. No. 771704). Ultra-LEAF™ purified anti-mouse CD152 (clone A21140B) (purple squares) inhibits the binding in a dose-dependent manner, whereas the Ultra-LEAF™ purified rat IgG1, κ isotype control (Cat. No. 400432) (gray triangles) does not have effect. This antibody blocks the binding of 0.05 µg/mL biotinylated mouse (CTLA-4)-Fc chimera to 1 µg/mL immobilized recombinant mouse CD86-FC chimera. ND50 range: 0.01 - 0.06 µg/mL . -
Recombinant mouse CTLA-4-Fc chimera (Cat. No. 591802) (black circles) inhibits the production of human IL-2 induced by mouse B7.1 (CD80)-Fc chimera (Cat. No. 555404) in Jurkat cells. Ultra-LEAF™ purified anti-mouse CD152 (clone A21140B) (purple squares) neutralizes the inhibitory effect of recombinant mouse CTLA-4-Fc chimera at 0.75 µg/mL on IL-2 production induced by mouse B7.1 (CD80)-Fc chimera in Jurkat cells in a dose-dependent manner whereas the Ultra-LEAF™ purified rat IgG1, κ isotype control (gray triangles) (Cat. No. 400432) does not have effect. ND50 range: 0.4 - 2.5 µg/mL.
Cat # | Size | Price | Quantity Check Availability | Save | ||
---|---|---|---|---|---|---|
637753 | 100 µg | £301 | ||||
637754 | 1 mg | £784 |
Mouse CTLA-4 was initially identified by differential screening of a murine cytolytic cDNA library. It is a member of the IgG superfamily, and it encodes a 223 amino acid protein and possesses a single extracellular V domain, a transmembrane domain, and a cytoplasmic domain. CTLA-4 is ~30% homologous with CD28, and both bind to the same ligands (B7.1/CD80 and B7.2/CD86) although CTLA-4 binds with higher affinity than CD28. Parallel recognition of a specific MHC-peptide complex by the T-cell receptor and CD80 or CD86 by the costimulatory receptor CD28 results in T cell activation, cytokine production, proliferation, and differentiation. After the T cell activation process and upregulation of CTLA-4, co-ligation of the TCR to MHC-peptide complex and CTLA-4 to its ligands results in cell cycle arrest and the end to T cell activation. It has been suggested that the negative regulatory mechanism of CTLA-4 is mediated through trans-endocytosis of CD80 and CD86 (capture of ligands from opposing cells). The ligands are removed from the original cell and degraded inside of CTLA-4-expressing cells. As a result, the action of CD28 is impaired. Alternative splice variants of CTLA-4 have been described in mice and humans; these variants skip exon 2 (ligand-binding domain) or exon 3 (transmembrane domain). The ligand independent CTLA-4 is expressed in mice, but not in humans, and the soluble CTLA-4 (sCTLA-4) is expressed in mice and humans. CTLA-4 is constitutively expressed by Tregs, and they are an important source of sCTLA-4. It has been suggested that sCTLA-4 potentiates regulatory T cell function. High levels of sCTLA-4 in Tregs have been associated with type 1 diabetes (T1D) and other autoimmune diseases.
Product DetailsProduct Details
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Recombinant Mouse CTLA-4-Fc Chimera
- Formulation
- 0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
- Endotoxin Level
- Less than 0.01 EU/μg of the protein (< 0.001 ng/μg of the protein) as determined by the LAL test
- Preparation
- The Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
- Concentration
- The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.
- Application
-
Block - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by blocking the binding of 0.05 µg/mL recombinant biotinylated mouse (CTLA-4)-Fc (Cat. No. 779102) to immobilized 1 µg/mL recombinant mouse CD86-FC chimera (Cat. No. 771704). ND50 range: 0.01 - 0.06 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.
Antigen Details
- Structure
- Disulfide-linked homodimer, biotinylated via amines
- Distribution
-
Activated T cells, CD4, CD8, and Tregs
- Function
- Inhibits T cell activation by reducing IL-2 production and IL-2R expression, also arresting T cells in G1 phase of the cell cycle; protects against the development of autoimmunity
- Interaction
- Antigen presenting cells, B cells
- Ligand/Receptor
- CD80 (B7.1), CD86 (B7.2)
- Cell Type
- B cells, T cells, Tregs
- Biology Area
- Immunology
- Molecular Family
- CD Molecules, Immune Checkpoint Receptors
- Antigen References
-
- Linsley PS, et al. 1991. J Exp Med. 174:561-9.
- Pentcheva-Hoang T, et al. 2004. Immunity. 2:401-13.
- Qureshi OS, et al. 2011. Science. 332:600-3.
- Gerold KD, et al. 2011. Diabetes. 60:1955-63.
- Ryden A, et al. 2012. Diabetes Metab. Res. Rev. 28:84-96.
- Mittal AK, et al 2013. PloS One. 8:e70352.
- Ward FJ, et al. 2013. Eur J Immunol. 43:1274-85.
- Gene ID
- 12477 View all products for this Gene ID
- UniProt
- View information about CD152 on UniProt.org
Related FAQs
- Do you guarantee that your antibodies are totally pathogen free?
-
BioLegend does not test for pathogens in-house aside from the GoInVivo™ product line. However, upon request, this can be tested on a custom basis with an outside, independent laboratory.
- Does BioLegend test each Ultra-LEAF™ antibody by functional assay?
-
No, BioLegend does not test Ultra-LEAF™ antibodies by functional assays unless otherwise indicated. Due to the possible complexities and variations of uses of biofunctional antibodies in different assays and because of the large product portfolio, BioLegend does not currently perform functional assays as a routine QC for the antibodies. However, we do provide references in which the antibodies were used for functional assays and we do perform QC to verify the specificity and quality of the antibody based on our strict specification criteria.
- Does BioLegend test each Ultra-LEAF™ antibody for potential pathogens?
-
No, BioLegend does not test for pathogens in-house unless otherwise indicated. However, we can recommend an outside vendor to perform this testing as needed.
- Have you tested this Ultra-LEAF™ antibody for in vivo or in vitro applications?
-
We don't test our antibodies for in vivo or in vitro applications unless otherwise indicated. Depending on the product, the TDS may describe literature supporting usage of a particular product for bioassay. It may be best to further consult the literature to find clone specific information.
Other Formats
View All CD152 Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
Ultra-LEAF™ Purified anti-mouse CD152 | A21140B | Block |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
Ultra-LEAF™ Purified anti-mouse CD152
Biotinylated recombinant mouse (CTLA-4)-Fc chimera (Cat. No.... Recombinant mouse CTLA-4-Fc chimera (Cat. No. 591802) (black...
Follow Us